Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088354013> ?p ?o ?g. }
- W3088354013 abstract "Abstract Background Individuals with phenylalanine hydroxylase (PAH) deficiency lack an enzyme needed to metabolize the amino acid, phenylalanine. This leads to an increase of phenylalanine in the blood, which is associated with changes in cognitive and psychological functioning. Skilled clinical management is essential for preventing complications and providing comprehensive care to patients. In the last decade, the American College of Genetics and Genomics (ACMG) and a group of European experts developed separate guidelines to provide recommendations for the management and care of persons with PAH deficiency. The purpose of this paper was to compare and contrast these guidelines in order to understand the different approaches to PAH deficiency care. Methods We examined the procedures used to develop both guidelines, then evaluated key areas in PAH deficiency care which included screening, diagnostic approaches, dietary treatment (initiation and duration), ongoing phenylalanine level/ nutritional monitoring, neurocognitive screening, adherence issues in treatment, and special populations (women and maternal PKU, late or untreated PAH deficiency, and transitioning to adult services). We conducted a scoping review of four key topics in PAH deficiency care to explore recent research studies performed since the publication of the guidelines. Results The ACMG and European expert group identified limited numbers of high quality studies to use as evidence for their recommendations. The ACMG and European guidelines had many similarities in their respective approaches PAH deficiency care and recommendations for the diagnosis, treatment, and management for persons with PAH deficiency. There were also a number of differences between the guidelines regarding the upper range for phenylalanine levels in adolescents and adults, the types of instruments used and frequency of neuropsychiatric examinations, and monitoring of bone health. Treatment adherence can be associated with a number of challenges, such as aversions to medical foods and formulas, as well as factors related to educational, social, and psychosocial issues. From the scoping review, there were many new studies addressing issues in treatment and management including new research on sapropterin adherence and increased dietary protein tolerance and pegvaliase on the reduction in phenylalanine levels and hypersensitivity reactions. Conclusions In the last decade, ACMG and European experts developed comprehensive guidelines for the clinical management of phenylalanine hydroxylase deficiency. The guidelines offered background and recommendations for clinical care of patients with PAH deficiency throughout the lifespan. New research evidence is available and updates to guidelines can keep pace with new developments. Evidence-based guidelines for diagnosis and treatment are important for providing expert care to patients." @default.
- W3088354013 created "2020-10-01" @default.
- W3088354013 creator A5032636594 @default.
- W3088354013 creator A5049047009 @default.
- W3088354013 creator A5056161859 @default.
- W3088354013 date "2020-09-25" @default.
- W3088354013 modified "2023-10-03" @default.
- W3088354013 title "Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe" @default.
- W3088354013 cites W1977343599 @default.
- W3088354013 cites W1990591430 @default.
- W3088354013 cites W2001072757 @default.
- W3088354013 cites W2034645250 @default.
- W3088354013 cites W2037365975 @default.
- W3088354013 cites W2093734051 @default.
- W3088354013 cites W2097859384 @default.
- W3088354013 cites W2110312890 @default.
- W3088354013 cites W2124862267 @default.
- W3088354013 cites W2151598366 @default.
- W3088354013 cites W2286376354 @default.
- W3088354013 cites W2460747436 @default.
- W3088354013 cites W2555636149 @default.
- W3088354013 cites W2571094594 @default.
- W3088354013 cites W2572123485 @default.
- W3088354013 cites W2597054135 @default.
- W3088354013 cites W2601583588 @default.
- W3088354013 cites W2774793874 @default.
- W3088354013 cites W2779780278 @default.
- W3088354013 cites W2782327081 @default.
- W3088354013 cites W2792648556 @default.
- W3088354013 cites W2795291721 @default.
- W3088354013 cites W2808474736 @default.
- W3088354013 cites W2813027720 @default.
- W3088354013 cites W2860292422 @default.
- W3088354013 cites W2879234130 @default.
- W3088354013 cites W2889470037 @default.
- W3088354013 cites W2894354017 @default.
- W3088354013 cites W2895124926 @default.
- W3088354013 cites W2896380963 @default.
- W3088354013 cites W2897503368 @default.
- W3088354013 cites W2905358512 @default.
- W3088354013 cites W2942355434 @default.
- W3088354013 cites W2952835344 @default.
- W3088354013 cites W2964434744 @default.
- W3088354013 cites W2977519184 @default.
- W3088354013 cites W4246967298 @default.
- W3088354013 doi "https://doi.org/10.1186/s13023-020-01541-2" @default.
- W3088354013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7519570" @default.
- W3088354013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32977849" @default.
- W3088354013 hasPublicationYear "2020" @default.
- W3088354013 type Work @default.
- W3088354013 sameAs 3088354013 @default.
- W3088354013 citedByCount "6" @default.
- W3088354013 countsByYear W30883540132021 @default.
- W3088354013 countsByYear W30883540132022 @default.
- W3088354013 countsByYear W30883540132023 @default.
- W3088354013 crossrefType "journal-article" @default.
- W3088354013 hasAuthorship W3088354013A5032636594 @default.
- W3088354013 hasAuthorship W3088354013A5049047009 @default.
- W3088354013 hasAuthorship W3088354013A5056161859 @default.
- W3088354013 hasBestOaLocation W30883540131 @default.
- W3088354013 hasConcept C104317684 @default.
- W3088354013 hasConcept C118552586 @default.
- W3088354013 hasConcept C169900460 @default.
- W3088354013 hasConcept C172467417 @default.
- W3088354013 hasConcept C187212893 @default.
- W3088354013 hasConcept C207009774 @default.
- W3088354013 hasConcept C2777431362 @default.
- W3088354013 hasConcept C515207424 @default.
- W3088354013 hasConcept C54355233 @default.
- W3088354013 hasConcept C64474127 @default.
- W3088354013 hasConcept C71924100 @default.
- W3088354013 hasConcept C86803240 @default.
- W3088354013 hasConceptScore W3088354013C104317684 @default.
- W3088354013 hasConceptScore W3088354013C118552586 @default.
- W3088354013 hasConceptScore W3088354013C169900460 @default.
- W3088354013 hasConceptScore W3088354013C172467417 @default.
- W3088354013 hasConceptScore W3088354013C187212893 @default.
- W3088354013 hasConceptScore W3088354013C207009774 @default.
- W3088354013 hasConceptScore W3088354013C2777431362 @default.
- W3088354013 hasConceptScore W3088354013C515207424 @default.
- W3088354013 hasConceptScore W3088354013C54355233 @default.
- W3088354013 hasConceptScore W3088354013C64474127 @default.
- W3088354013 hasConceptScore W3088354013C71924100 @default.
- W3088354013 hasConceptScore W3088354013C86803240 @default.
- W3088354013 hasIssue "1" @default.
- W3088354013 hasLocation W30883540131 @default.
- W3088354013 hasLocation W30883540132 @default.
- W3088354013 hasLocation W30883540133 @default.
- W3088354013 hasOpenAccess W3088354013 @default.
- W3088354013 hasPrimaryLocation W30883540131 @default.
- W3088354013 hasRelatedWork W1975221163 @default.
- W3088354013 hasRelatedWork W2017306890 @default.
- W3088354013 hasRelatedWork W2136608363 @default.
- W3088354013 hasRelatedWork W2323528028 @default.
- W3088354013 hasRelatedWork W2327974017 @default.
- W3088354013 hasRelatedWork W2413829860 @default.
- W3088354013 hasRelatedWork W2964592753 @default.
- W3088354013 hasRelatedWork W4250373567 @default.
- W3088354013 hasRelatedWork W4294688244 @default.
- W3088354013 hasRelatedWork W4364358308 @default.